SIG
BMY icon

Sargent Investment Group’s Bristol-Myers Squibb BMY Stock Holding History

Sargent Investment Group’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.09M Buy
36,270
+340
+0.9% +$19.5K 0.25% 75
2026
Q1 		$2.18M Buy
35,930
+4,996
+16% +$291K 0.29% 70
2025
Q4 		$1.67M Buy
30,934
+5,246
+20% +$252K 0.21% 82
2025
Q3 		$1.16M Buy
25,688
+2,690
+12% +$126K 0.17% 89
2025
Q2 		$1.03M Buy
22,998
+3,260
+17% +$160K 0.14% 99
2025
Q1 		$1.2M Buy
19,738
+2,082
+12% +$121K 0.19% 83
2024
Q4 		$977K Buy
17,656
+8,387
+90% +$469K 0.16% 97
2024
Q3 		$480K Buy
+9,269
New +$435K 0.09% 122
2024
Q1 		– Sell
-5,741
Closed -$295K – 206
2023
Q4 		$295K Sell
5,741
-4,025
-41% -$211K 0.06% 166
2023
Q3 		$567K Buy
9,766
+521
+6% +$31.9K 0.14% 109
2023
Q2 		$591K Sell
9,245
-157
-2% -$10.5K 0.14% 108
2023
Q1 		$655K Buy
9,402
+75
+0.8% +$5.29K 0.17% 98
2022
Q4 		$671K Hold
9,327
– – 0.21% 92
2022
Q3 		$655K Sell
9,327
-446
-5% -$32.4K 0.2% 90
2022
Q2 		$753K Sell
9,773
-930
-9% -$70.8K 0.23% 81
2022
Q1 		$782K Buy
10,703
+116
+1% +$7.79K 0.2% 91
2021
Q4 		$660K Sell
10,587
-360
-3% -$21.1K 0.15% 102
2021
Q3 		$648K Buy
10,947
+335
+3% +$22.1K 0.16% 102
2021
Q2 		$709K Buy
10,612
+15
+0.1% +$978 0.17% 98
2021
Q1 		$669K Buy
10,597
+2,017
+24% +$125K 0.18% 99
2020
Q4 		$532K Buy
8,580
+4,395
+105% +$270K 0.17% 99
2020
Q3 		$252K Buy
+4,185
New +$252K 0.09% 141

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Sargent Investment Group's BMY Position: Q2 2026 in Review

Sargent Investment Group increased its Bristol-Myers Squibb (BMY) stake by 0.95% in Q2 2026, buying an estimated $19.5K and bringing the position to 36,270 shares worth $2.09M. The position accounts for 0.25% of the portfolio, ranked #75.

Sargent Investment Group first reported a position in BMY in Q3 2020 and has held it in 22 quarters since. The position peaked at $2.18M in Q1 2026. 2,524 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Sargent Investment Group held 36,270 shares of Bristol-Myers Squibb worth $2.09M as of Q2 2026.
  • Sargent Investment Group bought 340 Bristol-Myers Squibb shares in Q2 2026, an estimated $19.5K.
  • Bristol-Myers Squibb made up 0.25% of Sargent Investment Group's portfolio in Q2 2026, its #75 holding.
  • Sargent Investment Group first reported a position in Bristol-Myers Squibb in Q3 2020 and has held it in 22 quarters since.
  • Sargent Investment Group's Bristol-Myers Squibb position peaked at $2.18M in Q1 2026.
  • 2,524 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Sargent Investment Group's 13F filing for Q2 2026, filed 11 Aug 2026.